Proteome-wide analyses have shown that EV biogenesis is altered during preclinical AD, with the presence of specific proteins such as MHC class-type markers, prion protein (PrP), and amyloid protein (APP) [17]. The gene discussed is PRNP; the disease is Alzheimer disease.